´╗┐
 Return to QS52 Overview

Peripheral arterial disease [QS52]

Measuring the use of this guidance

Statement: 2

People with peripheral arterial disease (PAD) are offered an assessment for cardiovascular comorbidities and modifiable risk factors.

Quality standard measure: Proportion of people with PAD who receive an assessment of cardiovascular comorbidities and modifiable risk factors.
What was measured: PAD004: The percentage of patients with peripheral arterial disease with a record in the preceding 12 months that aspirin or an alternative anti-platelet is being taken.
Data collection end: March 2014
91.8%
Number that met the criteria: 269273 / 293238
Area covered: National
Source: Health and Social Care Information Centre. Quality and Outcomes Framework.

Quality standard measure: Proportion of people with PAD who receive an assessment of cardiovascular comorbidities and modifiable risk factors.
What was measured: PAD003: The percentage of patients with peripheral arterial disease in whom the last measured total cholesterol (measured in the preceding 12 months) is 5 mmol/l or less.
Data collection end: March 2014
81.9%
Number that met the criteria: 249807 / 305216
Area covered: National
Source: Health and Social Care Information Centre. Quality and Outcomes Framework.

Quality standard measure: Proportion of people with PAD who receive an assessment of cardiovascular comorbidities and modifiable risk factors.
What was measured: PAD002: The percentage of patients with peripheral arterial disease in whom the last blood pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less.
Data collection end: March 2014
90.3%
Number that met the criteria: 309858 / 343046
Area covered: National
Source: Health and Social Care Information Centre. Quality and Outcomes Framework.



 Return to QS52 Overview